PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31693535-7 2020 The reductions of SBP and DBP were notably greater when nebivolol was used as monotherapy in de novo patients (P < 0.0001) and as add-on therapy to existing antihypertensives (angiotensin II receptor blockers, angiotensin-converting enzyme inhibitors and calcium channel blockers; P < 0.0001). Calcium 255-262 selenium binding protein 1 Homo sapiens 18-21 29421796-9 2018 Controlling volume variation, avoiding hypoalbuminemia and reducing blood calcium levels might reduce SBP variability and thereby improve prognoses in these patients. Calcium 74-81 selenium binding protein 1 Homo sapiens 102-105 27379537-9 2016 In multivariate regression analyses, with adjustment for age, sex, PTH, FGF-23, traditional cardiovascular risk factors, antihypertensive medication and parameters of calcium metabolism ARR remained significantly and directly related with nocturnal BP (SBP: adjusted beta-coefficient = 0.289, P < 0.01; DBP: beta = 0.399, P < 0.01). Calcium 167-174 selenium binding protein 1 Homo sapiens 253-256 27087421-6 2016 The results revealed that vitamin C, potassium, and calcium losses in sweat were positively correlated with systolic (SBP) and diastolic (DBP) blood pressure (all P<0.05). Calcium 52-59 selenium binding protein 1 Homo sapiens 118-121 27087421-7 2016 A linear stepwise regression analysis revealed that potassium, and calcium losses in sweat adversely affected SBP and DBP (all P<0.05). Calcium 67-74 selenium binding protein 1 Homo sapiens 110-113 27087421-8 2016 An analysis of covariance showed that SBP increased when potassium or calcium losses in sweat were >900 mg, or >100 mg, respectively. Calcium 70-77 selenium binding protein 1 Homo sapiens 38-41 25485720-11 2015 In RCTs comparing calcium antagonists, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) with placebo smaller SBP/DBP differences were achieved, mostly because in the majority of these later RCTs the antihypertensive drug and placebo were added on a background treatment with other antihypertensive agents. Calcium 18-25 selenium binding protein 1 Homo sapiens 148-151 22796715-9 2012 Modification effect of sex was observed for saturated fatty acids intake (positive association with DPB in women) and calcium (negative association with SBP in men). Calcium 118-125 selenium binding protein 1 Homo sapiens 153-156 22499291-8 2012 Visit-to-visit intraindividual clinic SBP variability was only slightly lower on calcium antagonist than on beta-blocker treatment but little or no between-treatment difference was found for visit-to-visit clinic DBP and ambulatory SBP/DBP particularly in patients under monotherapy throughout the study. Calcium 81-88 selenium binding protein 1 Homo sapiens 38-41 20461205-8 2010 Among 30~49-year-olds, calcium was inversely associated with both SBP and DBP (P = 0.012 and 0.010, respectively). Calcium 23-30 selenium binding protein 1 Homo sapiens 66-69 16379774-0 1998 Calcium supplementation during pregnancy was associated with lower SBP in the children. Calcium 0-7 selenium binding protein 1 Homo sapiens 67-70 8207737-6 1994 SBP during surgery was found to be related to the in vitro measured [Ca2+]i in the parathyroid cells at 3.0 mM extracellular calcium concentration or to the ratio of [Ca2+]i at 3.0 mM-0.5 mM (r = -0.25 and -0.27, respectively; P < 0.05). Calcium 125-132 selenium binding protein 1 Homo sapiens 0-3 34798910-6 2021 RESULTS: After adjusting potential confounding factors (age, sex, BMI, height, weight, SBP, DBP, TC, LDL-C, HDL-C, triglycerides, smoking status, alcohol consumption, reflux esophagitis status, hypertension, diabetes, dyslipidemia, ischemic heart disease and cerebrovascular disease), it was revealed that there was a nonlinear relationship between HbA1c and coronary artery calcium score progression, while the scoring point was 5.8%. Calcium 375-382 selenium binding protein 1 Homo sapiens 87-90 34849291-10 2021 CONCLUSION: The study showed the efficacy of Calcium Channel Blocker, Beta Blocker and Angiotensin Receptor Blocker in reduction of SBP & DBP was same, while Calcium Channel Blockers were superior to other two medications. Calcium 45-52 selenium binding protein 1 Homo sapiens 132-135 2491521-2 1989 The treated with calcium showed a significant decrease in blood pressure (BP), the maximal reduction being of 6 mm Hg in the systolic pressure (SBP) and 3 mm in the diastolic (DBP) at the end of the 8th week. Calcium 17-24 selenium binding protein 1 Homo sapiens 144-147 3241258-8 1988 Urinary calcium (creatinine) was negatively correlated with SBP in males, and with SBP and DBP in the south. Calcium 8-15 selenium binding protein 1 Homo sapiens 60-63 3241258-8 1988 Urinary calcium (creatinine) was negatively correlated with SBP in males, and with SBP and DBP in the south. Calcium 8-15 selenium binding protein 1 Homo sapiens 83-86